No abstract

We conducted a survey of attitudes towards antimicrobial use and awareness of antimicrobial resistance among turkey and rabbit farmers (N ¼ 117 and N ¼ 41, respectively) in Italy's utmost turkey-and rabbit-producing region. We found either similarities or significant differences between these two livestock sectors. Most farmers of both groups (72% of turkey farmers vs 76% of rabbit farmers) reported that antimicrobials are properly used in their farms. Almost three-quarters of the farmers reported that antimicrobials solve the health problem treated for. However, 47% of turkey farmers and 78% of rabbit farmers reported that antimicrobial use could be decreased, with a 20-30% reduction being the most frequently chosen range. Genetic improvement was reported to be the main factor able to reduce antimicrobial use in turkeys, whereas improvements in feed quality and microclimate were the main factors for rabbits. Most farmers reported that high antimicrobial use may affect the quality of meat products and be hazardous to human health, but they also reported that antimicrobial resistance is mainly related to antimicrobial use in humans. In conclusion, turkey and rabbit farmers have a generally positive opinion on veterinary antimicrobial use, but also low levels of awareness of the negative impact on public health. Economic and structural factors of rabbit production industry may explain the differences observed. Farm veterinarians will be crucial to support farmers' education and the expected transition to lower antimicrobial use while maintaining high animal health/ welfare standards. HIGHLIGHTS 47% of turkey vs. 78% of rabbit farmers thought that antimicrobial use can be decreased A 20-30% reduction of antimicrobials was the most frequently supposed range Turkey and rabbit farmers showed a low level of awareness of the negative impact of antimicrobial usage in their farms on human health ARTICLE HISTORY

No abstract

The present study investigated the occurrence of anaerobic intestinal spirochaetes of the genus Brachyspira in laying hen flocks in Treviso province, north-eastern Italy, with respect to prevalence, spirochaete species present, disease associations and risk factors for colonization. A total of 450 faecal samples from 45 sheds on 29 laying hen farms were cultured for intestinal spirochaetes. Nineteen sheds on 12 farms contained chickens with symptoms consistent with avian intestinal spirochaetosis, including reduced egg production, wet litter and/or pasty vents. Spirochaetes were isolated from 157 (34.8%) samples from 21 (72.4%) farms, and from 32 (71.1%) sheds. From these positive samples, 189 spirochaetal isolates were speciated using three polymerase chain reaction assays and a restriction fragment polymorphism analysis of 16S rDNA polymerase chain reaction products. Overall, 52 (27.5%) isolates were identified as pathogenic Brachyspira intermedia, 26 (13.8%) as pathogenic Brachyspira pilosicoli, 93 (49.7%) as non-pathogenic (Brachyspira innocens/Brachyspira murdochii), and 18 (9.6%) were unidentified. Faeces from 14 sheds (31%) on 10 farms (34.5%) contained B. intermedia and/or B. pilosicoli, and disease consistent with avian intestinal spirochaetosis was observed in nine of these sheds on seven farms. There was a significant association (P00.042) between the presence of spirochaetes and using deep pits rather than conveyor belts for manure disposal. Sheds housing chickens 40 weeks of age were significantly more likely to contain spirochaetes (P00.048) and pathogenic species (P 0007) than sheds housing younger chickens. A significant association (P 00.02) was found between infection with pathogenic spirochaetes and reduced egg production.

No abstract

No abstract

No abstract

Reliable indicators of antimicrobial consumption (AMC) measured with harmonised data and supported by indicators for antimicrobial resistance (AMR) at herd level are necessary to target antimicrobial misuse in food-producing animals. AMC data in 2010-2015 in 32 Italian industrial rabbit holdings weighted with semester production and standardised with animal daily doses (ADDs) were collected. Herd-level AMR against eight antimicrobials was assessed in Escherichia coli, Enterococcus faecalis and Enterococcus hirae collected in 2014-2015. Escherichia coli were assessed for mcr-1 and mcr-2 genes. To produce 1 kg of live rabbit, a mean of 71.8 ADDs was used. Overall AMC reduced over time (P < 0.05) owing to lowering consumption of tetracyclines (P < 0.05) and colistin (P < 0.01), but consumption of quinolones (P < 0.05), bacitracin (P < 0.01) and sulfonamides (P = 0.017) increased. All except one indicator E. coli were wild-type for cefotaxime, whereas 97% displayed reduced susceptibility to tetracyclines, 89% to trimethoprim, 63% to enrofloxacin, 24% to chloramphenicol and 21% to colistin. mcr-1 was detected in 50/320 E. coli isolates from 15/32 holdings; mcr-2 was not detected in 58 isolates with colistin MIC ≥ 2 mg/L. All 305 enterococci were wild-type for ampicillin, ciprofloxacin and vancomycin and displayed reduced tetracycline susceptibility. The mean antimicrobial resistance index (ARI) was 0.5 for E. coli and 0.3 for enterococci. ARI was significantly correlated with AMC at herd level for enterococci (P = 0.008) but not E. coli where high ARI levels were found in a few holdings with low AMC.